Status:
ACTIVE_NOT_RECRUITING
Sensitivity to Acute Cerebral Ischemia in Migrainers
Lead Sponsor:
University Hospital, Montpellier
Conditions:
Ischemic Stroke
Migraine
Eligibility:
All Genders
18-85 years
Brief Summary
Sensitivity to Acute Middle cerebral or intracranial Carotid artery Occlusion in MIGrainers (SMCO-MIG) is a prospective multi-center study to determine if migraine induces a faster infarct growth as a...
Detailed Description
Ischemic stroke results from the occlusion of a brain artery by a clot. Early revascularization by thrombolysis and thrombectomy promotes neurological recovery by saving the area of ischemic penumbra....
Eligibility Criteria
Inclusion
- Males and females, 18 to 75 years old
- Admitted to a stroke unit for an acute ischemic stroke (\<12 h)
- Angiography showing M1/M2 or intracranial internal carotid artery occlusion
- MRI or CT acquired \<24h from IS onset, using a harmonized protocol enabling calculation of the mismatch
Exclusion
- Individual enrolled into another study protocol with a period of exclusion still running at potential inclusion
- Coma, dementia, linguistic problem or aphasia preventing responding to the migraine questionnaire
- Refusal of participation
- Persons under legal protection, guardianship or curatorship
Key Trial Info
Start Date :
February 9 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2024
Estimated Enrollment :
605 Patients enrolled
Trial Details
Trial ID
NCT03301441
Start Date
February 9 2018
End Date
July 1 2024
Last Update
May 29 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Montpellier - Neurology Departement
Montpellier, France